Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Elective preterm birth for earlier spinal muscular atrophy treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
Spinal muscular atrophy treatment in patients identified by newborn screening – a systematic review
10.3390/genes14071377 · 2023 · External reference
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
10.2147/tcrm.s172291 · 2019 · External reference
Gestational Age at Birth and Clinical Manifestations of Spinal Muscular Atrophy
10.1212/wnl.0000000000213799 · 2025 · External reference
Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy
10.1056/nejmc2300802 · 2025 · External reference
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
10.1016/j.nmd.2019.09.007 · 2019 · External reference
Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children
10.1002/acn3.51449 · 2021 · External reference
Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges
10.1515/cclm-2023-1311 · 2024 · External reference
Unresolved reference
2025 · External reference
Onasemnogene-abeparvovec administration to premature infants with spinal muscular atrophy
10.1002/acn3.52213 · 2024 · External reference
